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Abstract
Purpose: Repeat computed tomography (CT) simulation is problematic because of additional
expense of clinic resources, patient inconvenience, additional radiation exposure, and treatment
delay. We investigated the factors and clinical impact of unplanned CT resimulations in our
network.
Methods and Materials: We used the billing records of 18,170 patients treated at 5 clinics. A total
of 213 patients were resimulated before their first treatment. The disease site, location, use of 4-
dimensional CT (4DCT), contrast, image fusion, and cause for resimulation were recorded. Odds
ratios determined statistical significance.
Results: Our total rate of resimulation was 1.2%. Anal/colorectal (P < .001) and head and neck
(P < .001) disease sites had higher rates of resimulation. Brain (P Z .001) and lung/thorax
(PZ .008) had lower rates of resimulation. The most common causes for resimulation were setup
change (11.7%), change in patient anatomy (9.8%), and rectal filling (8.5%). The resimulation rate
for 4DCTs was 3.03% compared with 1.0% for non-4DCTs (P < .001). Median time between
simulations was 7 days.
Conclusions: The most common sites for resimulation were anal/colorectal and head and neck,
largely because of change in setup or changes in anatomy. The 4DCT technique correlated with
higher resimulation rates. The resimulation rate was 1.2%, and median treatment delay was 7 days.
Further studies are warranted to limit the rate of resimulation.
 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation
Oncology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Modern radiation treatment planning primarily uses
computed tomography (CT) imaging for target delinea-
tion. A resimulation is when a repeat CT scan is necessary
after the initial planning scan. Some resimulations are
planned in the middle of treatment as a result of tumor
shrinkage or patient weight loss, as is commonly seen in
head and neck (H&N) treatment.1 An unplanned resi-
mulation occurs when there is an unforeseen problem
with the initial planning scan before the initiation of
treatment delivery, thus requiring a repeat simulation.
Causes of resimulation include but are not limited to
bladder or rectal filling, exaggerated respiratory motion,
image artifact, inappropriate treatment setup, and change
in patient anatomy.
Achieving the desired reproducible anatomy of a pa-
tient, both externally and internally, can be difficult
because of patient factors or noncompliance.2 For
instance, patients with pelvic tumors are often simulated
with a full bladder and empty rectum to move the small
bowel out of the field and allow for a consistent treatment
setup. Variations in bladder filling and influence of bowel
preparation are well documented for pelvic tumors such
as in the prostate, gynecologic malignancies, and rectal
cancer.3-5 Inappropriate bladder/rectal filling on the initial
CT can require a resimulation to optimize dosimetry in
treatment planning. Beyond patient-related factors, com-
plex setups and suboptimal image quality may necessitate
a resimulation. For example, the respiratory motion
accounted for by a 4-dimensional CT (4DCT) adds
complexity to the CT simulation acquisition and may
result in image artifact from irregular respiration.6,7 Ulti-
mately, the causes of resimulation are multifactorial and
can be unpredictable.
In addition to added cost, time, and radiation exposure,
resimulations may cause a delay in planning and treat-
ment, which has been associated with poorer survival
throughout various disease sites.8-11 To our knowledge no
publications have quantified unplanned resimulations.
Therefore we analyzed the incidence of resimulations and
their precipitating causes within our network.
Methods and Materials
In this institutional review boardeexempt quality
assurance (QA) study, we used the billing records of
18,170 consecutive cases treated within our integrated
cancer network from August 2005 to December 2017 to
identify all the instances of resimulation performed within
that period. Patients were treated at 5 radiation oncology
clinics: 4 community practices and 1 academic setting.
There were a total of 11 treating physicians, all of whom
still practice in our department. Additionally, the system
director of the network and clinical operation physician
for each clinic remained the same through all the years
included in this study. We conducted a search using the
departmental code for resimulation in our electronic
medical record (Mosaiq-Elekta, Version 2.64; Elekta,
Inc). A total of 453 patients were resimulated at least
1 day after the initial simulation. To eliminate planned
resimulation, the following were excluded: patients who
were resimulated after the treatment start date and any
planned resimulation such as after prostate seed place-
ment or after high-dose-rate balloon breast brachytherapy
(n Z 240). Ultimately, 213 patients underwent an un-
planned resimulation before first treatment. The disease
site and the cause leading to resimulation were recorded
as detailed in Tables 1 and 2. The additional factors
evaluated included the treatment clinic, use of 4DCT, use
of intravenous/oral (IV/PO) contrast, and positron emis-
sion tomography (PET)-CT image fusion. The time be-
tween initial CT simulation and resimulation was also
recorded.
For the statistical analysis, we calculated the percent-
ages for each of the resimulation parameters being eval-
uated: disease site, common causes, 4DCT, IV/PO
contrast, and PET-CT fusion. We then conducted a uni-
variate binomial regression analysis for each disease site
delineated via odds ratios using c2 testing for statistical
significance. The control used for our statistics was the
total number of patients treated for each disease site.
Microsoft Excel 2010 was used for statistical analysis.
Results
The total rate of resimulation at the 5 radiation
oncology clinics evaluated was 1.2%. Anal/colorectal
(P < .001; odds ratio [OR], 2.72; confidence interval [CI],
1.73-4.30) and head and neck (P < .001; OR, 2.67; CI,
1.70-4.22) disease sites were associated with significantly
higher rates of resimulation. Brain (P Z .001; OR, 0.38;
CI, 0.22-0.66) and lung/thorax (P Z .008; OR, 0.48; CI,
0.28-0.82) were associated with significantly lower rates
of resimulation. No other disease site was found to be
statistically significant for being either more or less at risk
for resimulation. Each disease site’s reported resimulation
rates and the most common corresponding cause for each
site are listed in Table 1. Eighty percent of cases reviewed
provided sufficient documentation to elicit the cause for
resimulation. The most common documented causes
included setup change (11.7%), change in patient anat-
omy between initial simulation and treatment (9.8%), and
rectal filling (8.5%). The 3 most common causes of a
setup change were repositioning of the arm, head/feet
first, and head extension. The causes of resimulation and
the percentage of time each reason occurred are displayed
in Table 2.
Factors evaluated included the use of 4DCT, IV/PO
contrast, and PET/CT fusion. The 4DCT resimulation rate
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was 3.03% compared with 1.0% for non-4DCT
(P < .001; OR, 2.64; CI, 1.67-4.16). Use of IV/PO
contrast or PET/CT fusion did not reach statistical sig-
nificance. There was also no difference in rates of resi-
mulation between academic and community setting.
Median time between initial simulation and resimulation
was 7 days (range, 1-143). Excluding those who received
systemic therapy before resimulation, the median time
between initial simulation and resimulation was 6 days
(range, 1-29).
Discussion
Unforeseen repeat CT simulations are an inevitable
part of every radiation oncology practice. Within our
network, the overall rate of resimulation was relatively
low at 1.2%, although because to our knowledge this is
the first study of its kind, no published data exist for
comparison. The possible treatment delay, added cost,
and patient inconvenience from resimulations merit ef-
forts to mitigate their occurrence. Although small, addi-
tional radiation exposure from a resimulation also
warrants an attempt to decrease its incidence.12 Some
resimulations will be unavoidable, but many can be
Table 1 Each disease site, their resimulation rate, and most common cause
Disease site Resimulation
rate
No. of patients
resimulated
Total no. of
patients
P value and OR (95% CI) Most common cause
Anal/colorectal 3.13% 21 670 P < .001 Supine vs prone
OR, 2.72, 1.73-4.30
Head and neck 3.07% 21 683 P < .001 1a. Chemotherapy first
OR, 2.67, 1.70 -4.22 1b. Change in anatomy*
Sarcoma 2.91% 5 172 NS Setup change
Skin 2.05% 9 440 NS 1a. Radiation therapy plan
change
1b. Bolus placement*
Hepatobiliary 1.87% 11 589 NS Respiratory motion
Bone metastases 1.70% 21 1233 NS Setup change
Gynecologic 1.38% 9 654 NS CT scan length adjustment
Breast 1.14% 39 3407 NS Setup change
Prostate 1.04% 37 3556 NS Rectal filling
Esophagus/stomach 0.89% 3 336 NS Change in anatomyy
Pancreas 0.85% 3 351 NS Stomach filling
Lung/thorax 0.64% 14 2202 P Z .008 Respiratory motion
OR, 0.48, 0.28-0.82
Brain 0.53% 14 2659 P Z .001 Stereotactic radiosurgery
frame displacementOR, 0.38, 0.22-0.66
Lymphoma/multiple
myeloma
0.32% 2 627 NS 1a. Chemotherapy first
1b. Bolus placement*
Abbreviations: CT Z computed tomography; NS Z nonsignificant; OR Z odds ratio.
* Tie result.
y Among known causes.
Table 2 The occurrence rate of the most common reasons
for resimulation calculated out of the total number of
resimulations
Reason for
resimulation
Rate of
occurrence
No. of
patients
Unknown 20.19% 43
Setup change 11.73% 25
Change in anatomy 9.86% 21
Rectal filling 8.45% 18
Immobilization devices 6.57% 14
Other 6.57% 14
Prone/supine 4.69% 10
CT scan length adjustment 4.69% 10
Change in RT plan 4.69% 10
Chemotherapy/lupron first 4.22% 9
Respiratory motion 3.76% 8
Bladder filling 2.82% 6
Vacuum bag malfunction 2.82% 6
Imaging artifact 2.35% 5
Bolus placement 1.88% 4
SRS frame displacement 1.88% 4
Stomach filling 1.88% 4
Fusion difficulty 0.47% 1
Abbreviations: CT Z computed tomography; RT Z radiation
therapy; SRS Z stereotactic radiosurgery.
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limited through a better understanding of the more trou-
blesome disease sites and common causes.
Anal/colorectal and H&N disease sites had a statisti-
cally significant higher rate of resimulation. The simula-
tion for treatment of pelvic and gastroenterological
malignancies involves detailed decision making for each
individual case. Common considerations include bowel
sparing techniques (prone vs supine), bolus requirement,
genitalia sparing, patient comfort, bladder filling, and use
of IV/PO contrast. For example, prone positioning with a
belly board allows for improved bowel sparing; however,
it may present greater interfraction variability. A “frog-
legged” supine position decreases some of the skin folds
to mitigate the amount of radiation dermatitis.13,14 Taking
into account setup and internal dynamic factors, both anal
and colorectal radiation treatment could be considered at
risk for resimulation. The most common reason for resi-
mulation in this patient subgroup was determining the
prone or supine position, likely to optimize bowel
sparing. Physicians may find it beneficial to scrutinize the
initial CT simulation for the presence of small bowel in
the treatment field and, if needed, address this with a
change in the patient’s position.
H&N patients offer a unique management challenge
because they may have significant anatomic changes
during the course of their treatment.15 Before the initiation
of therapy, these tumors are known to be aggressive, with
an in vitro potential doubling time as short as <6 days.16
In most patients a treatment delay of as little as 4 weeks
can lead to significant tumor progression both in growth
of the primary as well as new lymph node metastases.17
The most common causes for resimulation in these pa-
tients were change in anatomy and change in plan to
receive chemotherapy first. The aggressive nature of these
tumors can explain both of these causes for resimulation
and reflects the importance of starting treatment as soon
as possible.
The lung and brain disease sites were statistically
significant for having lower rates of resimulation. Sim-
ulations for lung treatment plans vary considerably
depending on the definitive or palliative nature of the
case. This was not accounted for in this study and may
have led to a lower rate of resimulation because this is
less likely in simple palliative lung plans. However,
4DCT scans, used in nearly all definitive lung cases,
were found to have a statistically significant higher
resimulation rate. Unsurprisingly, the most common
cause for resimulation in the lung subgroup was exag-
gerated respiratory motion, further indicating that most
definitive lung treatments are associated with a higher
resimulation rate. Brain treatment for either primary
brain tumors or brain metastases is similar in its setup for
each patient. Patients are simulated with a thermoplastic
mask or head frame for customized immobilization. The
lower rate of resimulation likely reflects the typical
standard approach to treatment.
The most common known cause for resimulation was
change in setup, at 11.7% of the total resimulations.
Repositioning the patient was the most common cause for
resimulation in this category. For example, the simulation
for a breast patient usually involves the patient lying in a
supine position, on a wedge cushion, with the patient’s
arms overhead.18 The arm position sometimes requires
adjustment if it is in the treatment field, which would
require a resimulation. H&N disease sites are simulated in
a supine position, with some sites requiring the head
extended to allow the oral cavity to be displaced from the
field and the shoulders down to minimize the potential for
beam interference.19 However, sometimes the amount of
head extension is limited because of patient discomfort,
which could also lead to resimulation.20
An attempt to distinguish between random occurrences
and systemic processes as the culprit behind resimulation
was difficult because what appears to be a random
occurrence can be influenced by a systematic process. For
instance, patients with prostate cancer are educated at the
time of consult and reminded the day before simulation,
with both verbal and written instructions, to have a full
bladder and empty rectum at time of simulation. How-
ever, as reflected in our study, this desired reproducible
anatomy is not always attainable for prostate simulations
and represents the number one cause for prostate resi-
mulation. This patient factor/random occurrence still oc-
curs despite a thorough QA program. This prompts the
question of whether additional measures can be taken to
improve the QA program. Dawdy et al21 recognized the
need for resimulation in many patients with prostate
cancer. This prompted them to improve patient pre-
paredness through a randomized study evaluating a
multimedia patient education tool (YouTube video) in
addition to verbal reminders and flyers. Patients indicated
they felt more prepared for their treatment, although there
was no statistical difference between the multimedia
group and verbal reminders/flyereonly group in the
rescanning rate.21 Strategies to mitigate resimulations for
each disease site can be incorporated into ever-evolving
QA improvements.
It is important that clinics attempt to mitigate the rate
of resimulations and successful solutions be communi-
cated to the radiation oncology community. We believe
additional QA steps integrated into the CT simulation
workflow at our institution may be beneficial in
decreasing the rate of resimulations. The first QA step is
performing a “time out” before a simulation. This will
allow the physician to familiarize the team with the pa-
tient while highlighting important details of the setup and
to communicate difficulties that may arise. In addition, it
ensures the orders for the simulation are accurate and will
allow the team members to voice concerns. A second
intervention would be the formulation of a physician
checklist that highlights important aspects for each site,
such as bladder/rectal filling, small bowel location, patient
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positioning, respiratory motion for 4DCTs, and so on.
These checklists will then be used to scrutinize certain
aspects of the CT simulation before the patient gets off the
table. Both interventions communicate to the team the
importance of the CT simulation and will help start a
discussion within a clinic and in the radiation oncology
community on potential solutions to help mitigate
resimulations.
In our study the median time between initial planning
and resimulation was 7 days. Limiting treatment delay to
improve both radiobiological and clinical outcomes has
been consistently projected in the literature. Malignancies
as aggressive as small cell lung cancer and as curable as
breast cancer have both been associated with poorer
outcomes if time to radiation therapy is not optimized.9,22
H&N and cervical tumors are likely the most described
diseases for which any delay in treatment can be detri-
mental to survival and can lead to higher rates of
locoregional recurrence in both definitive and adjuvant
settings.8,9 Regardless of the disease site, every effort
should be made to limit treatment delays.
Other important considerations regarding resimula-
tions include the potential increased patient anxiety and
transportation burden that can arise with an additional
visit and repeat CT imaging. Anxiety at the start of any
radiation therapy treatment course is common.23,24 The
effects of treatment-related anxiety can contribute to fa-
tigue, side effects, and decreased quality of life.25,26
Avoiding the additional anxiety and transportation costs
associated with a resimulation was a motivation in the
study on improving preparedness for initial simulations
for patients with prostate cancer discussed earlier.22
An additional consideration is the added radiation
exposure from a repeat CT scan.12 The CT scan increases
the dose to organs at risk outside the radiation field and
could theoretically increase the risk of a secondary ma-
lignancy.27 Furthermore, close attention is required with a
4DCT simulation because these had a higher rate of
resimulation, and 4DCT scans can have a radiation dose 2
to 4 times higher than that of a conventional CT scan.28
However, obtaining a quality CT simulation is essential,
and this exposure is small compared with the total dose
delivered during a radiation course.
This study is limited by its retrospective nature and
selection bias therein. As described earlier, clinicians may
find it difficult to interpret the data because some causes
for resimulation were random occurrences, whereas others
were due to systemic errors, making attempts to discern
these causes challenging. In addition, the QA processes
integrated into our CT simulation workflow may differ
from those of other institutions, affecting the resimulation
rate and the balance between random versus systemic
causes. Although a detailed search through medical re-
cords was used to uncover causes of resimulations,
documented reasons were not available in 20% of resi-
mulation cases. However, the most common disease sites
of the unknown group were breast and prostate, which
was similar to the known group and thus is likely
consistent with the rest of our data.
Conclusions
To our knowledge this is the first study to quantify the
rate of unplanned resimulation and the common reasons
they occur. At our institution the resimulation rate was
low at 1.2% and resulted in a median treatment delay of
7 days. Resimulations were most commonly needed for
anal/colorectal and H&N disease sites, largely because of
setup error or changes in anatomy. The data presented
here may be helpful in implementing QA strategies and
prospective studies to mitigate unplanned resimulations
and improve the overall quality of radiation treatment
delivery.
References
1. Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT
imaging and replanning during the course of IMRT for head-and-
neck cancer. Int J Radiat Oncol Biol Phys. 2006;64:355-362.
2. Cramp L, Connors V, Wood M, Westhuyzen J, McKay M,
Greenham S. Use of a prospective cohort study in the development
of a bladder scanning protocol to assist in bladder filling consistency
for prostate cancer patients receiving radiation therapy. J Med
Radiat Sci. 2016;63:179-185.
3. Heng SP, Low SH, Sivamany K. The influence of the bowel and
bladder preparation protocol for radiotherapy of prostate cancer
using kilo-voltage cone beam CT: Our experience. Indian J Cancer.
2015;52:639-644.
4. Eminowicz G, Motlib J, Khan S, Perna C, McCormack M. Pelvic
organ motion during radiotherapy for cervical cancer: Understand-
ing patterns and recommended patient preparation. Clin Oncol (R
Coll Radiol). 2016;28:e85-e91.
5. Chang JS, Yoon HI, Cha HJ, et al. Bladder filling variations during
concurrent chemotherapy and pelvic radiotherapy in rectal cancer
patients: Early experience of bladder volume assessment using ul-
trasound scanner. Radiat Oncol J. 2013;31:41-47.
6. Pan T, Martin RM, Luo D. New prospective 4D-CT for mitigating
the effects of irregular respiratory motion. Phys Med Biol. 2017;62:
N350-N361.
7. Li G, Caraveo M, Wei J, et al. Rapid estimation of 4DCT motion-
artifact severity based on 1D breathing-surrogate periodicity. Med
Phys. 2014;41:111717.
8. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect
of treatment delay on outcome of patients with early-stage head-and-
neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol
Biol Phys. 2002;52:929-936.
9. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does
delay in starting treatment affect the outcomes of radiotherapy? A
systematic review. J Clin Oncol. 2003;21:555-563.
10. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of
treatment prolongation in cervical carcinoma. Int J Radiat Oncol
Biol Phys. 1995;32:1301-1307.
11. Cattaneo R, Hanna RK, Jacobsen G, Elshaikh MA. Interval between
hysterectomy and start of radiation treatment is predictive of
recurrence in patients with endometrial carcinoma. Int J Radiat
Oncol Biol Phys. 2014;88:866-871.
12. Brenner DJ, Hall EJ. Computed tomographydan increasing source
of radiation exposure. N Engl J Med. 2007;357:2277-2284.
720 A. Metzger et al Advances in Radiation Oncology: OctobereDecember 2019
13. Scher ED, Ahmed I, Yue NJ, Jabbour SK. Technical aspects
of radiation therapy for anal cancer. J Gastrointest Oncol. 2014;5:
198-211.
14. Kim TH, Chie EK, Kim DY, et al. Comparison of the belly board
device method and the distended bladder method for reducing
irradiated small bowel volumes in preoperative radiotherapy of
rectal cancer patients. Int J Radiat Oncol Biol Phys. 2005;62:769-
775.
15. Barker JL, Garden AS, Ang KK, et al. Quantification of volumetric
and geometric changes occurring during fractionated radiotherapy
for head-and-neck cancer using an integrated CT/linear accelerator
system. Int J Radiat Oncol Biol Phys. 2004;59:960-970.
16. Bourhis J, DendaleR,Hill C, et al. Potential doubling time and clinical
outcome in head and neck squamous cell carcinoma treated with 70
GY in 7 weeks. Int J Radiat Oncol Biol Phys. 1996;35:471-476.
17. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in
waiting time for radiotherapy in head and neck cancer. Radiother
Oncol. 2007;84:5-10.
18. Varga Z, Hideghéty K, Mezo T, Nikolényi A, Thurzó L, Kahán Z.
Individual positioning: A comparative study of adjuvant breast
radiotherapy in the prone versus supine position. Int J Radiat Oncol
Biol Phys. 2009;75:94-100.
19. Lee NY, Riaz N, Lu JJ, eds. Target Volume Delineation for
Conformal and Intensity-Modulated Radiation Therapy. Heidelberg,
Germany: Springer Cham; 2015.
20. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM.
Intensity-modulated radiation therapy for head-and-neck cancer:
The UCSF experience focusing on target volume delineation. Int J
Radiat Oncol Biol Phys. 2003;57:49-60.
21. Dawdy K, Bonin K, Russell S, et al. Developing and evaluating
multimedia patient education tools to better prepare prostate-cancer
patients for radiotherapy treatment (randomized study). J Cancer
Educ. 2018;33:551-556.
22. Wyatt RM, Beddoe AH, Dale RG. The effects of delays in radio-
therapy treatment on tumour control. Phys Med Biol. 2003;48:139-
155.
23. Elsner K, Naehrig D, Halkett GKB, Dhillon HM. Reduced patient
anxiety as a result of radiation therapist-led psychosocial support: A
systematic review. J Med Radiat Sci. 2017;64:220-231.
24. Steven G, Renz P, Werts M, Werts ED. Determining the impact of a
pre-treatment “dry run” by analyzing intradepartmental reported
incidents and surveying staff and patients. Int J Radiat Oncol Biol
Phys. 2017;99:E562.
25. Gogou P, Tsilika E, Parpa E, et al. The impact of radiotherapy on
symptoms, anxiety and QoL in patients with cancer. Anticancer Res.
2015;35:1771-1775.
26. Courtier N, Gambling T, Enright S, Barrett-Lee P, Abraham J,
Mason MD. Psychological and immunological characteristics of
fatigued women undergoing radiotherapy for early-stage breast
cancer. Support Care Cancer. 2013;21:173-181.
27. Chien S-H, Liu C-J, Hu Y-W, et al. Frequency of surveillance
computed tomography in non-Hodgkin lymphoma and the risk of
secondary primary malignancies: A nationwide population-based
study. Int J Cancer. 2015;137:658-665.
28. Noid G, Tai A, Chen G-P, Robbins J, Li XA. Reducing radiation
dose and enhancing imaging quality of 4DCT for radiation therapy
using iterative reconstruction algorithms. Adv Radiat Oncol. 2017;2:
515-521.
Advances in Radiation Oncology: OctobereDecember 2019 Unforeseen CT resimulation 721
